Table 1.
Experimental group | Development to blastocysts (%) | Type A/B (%) | Type C/D/E (%) |
---|---|---|---|
Control (n=469) | 29.8 (n=140) | 52.9 (n=74) | 47.1 (n=66) |
BIO (n=167) | 31.1 (n=52) | 63.5 (n=33) | 36.5 (n=19) |
PD0325901 (n=177) | 36.7 (n=65) | 48.0 (n=31) | 52.0 (n=34) |
BIO+PD0325901 (n=133) | 36.8 (n=49) | 44.9 (n=22) | 55.1 (n=27) |
CHIR+PD0325901 (n=59) | 38.9 (n=23) | 52.2 (n=12) | 47.8 (n=11) |